-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Maravai LifeScience Holdings Inc. (MRVI)
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Misses Q1 EPS by 1c, provides guidance
-
-
-
-
-
-
-
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action - Hagens Berman
-
-
-
-
-
-
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
-
-
-
-
-
-
-
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending - Hagens Berman
-
448,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

